Replies to post #89235 on Titan Medical Inc (TMDIF)

[DRG1025]

I think you're exactly right. At the end of the day, this is still an R&D company, that even though they are at design freeze, still doesn't have a revenue generating/market approved product. Which is still classified as a risky investment. Granted, it is a lot less risky than two years ago, but still, considered "risky" in the securities trading world.